Thrombophilia Authors Maurizio Zangari University of Utah School of Medicine, Department of Hematology, Blood/Marrow Transplant and Myeloma, Salt Lake City, UT, U.S.A. Francesca Elice Department of Hematology, San Bortolo Hospital, Vicenza, Italy. Guido Tricot University of Utah School of Medicine, Department of Hematology, Blood/Marrow Transplant and Myeloma, Salt Lake City, UT, U.S.A. Louis Fink Nevada Cancer Institute, Las Vegas, Nevada, U.S.A. DOI: https://doi.org/10.33393/dti.2008.1336 Abstract No Abstract
Downloads PDF Issue Vol. 3 No. 1 (2008): January-December 2008 Section Review How to Cite Thrombophilia. (2008). Drug Target Insights, 3(1). https://doi.org/10.33393/dti.2008.1336 More Citation Formats ABNT ACM ACS APA Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Received 2020-01-07 Published 2008-04-16 Statistics Abstract: 1073 PDF: 630 Browse Sections Alternative Model Organisms Antimicrobial Resistance Phytotherapeutics and natural products Miscellaneous Journal Metrics Journal Impact Factor 2025: 3.75-year Impact Factor 2025: 3.8Journal Citation Indicator 2025: 0.66Scopus Citescore 2025: 4.7 banners150 Completed peer reviews since:June 5, 2020 Optimizing ChEMBL-derived QSAR models for natural flavonoid screening: chemotype-specific predictive reliability in α-glucosidase-inhibition 277 In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound 192 Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma 182 The role of patient preferences in adherence to treatment in chronic disease: a narrative review 178 Alternative model organisms: growing popularity, and the challenges 174